Form 4: Ginkgo Bioworks CFO Mark Dmytruk Reports Stock Transactions

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., reports multiple transactions involving Class A and Class B Common Stock, including acquisitions, disposals, and conversions, according to a Form 4 filing.

Summary

• Mark E. Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., filed a Form 4 detailing changes in beneficial ownership.
• The transactions occurred on July 1, 2024, and July 2, 2024.
• Dmytruk acquired Class A Common Stock through the vesting of restricted stock units (RSUs).
• He also converted Class B Common Stock to Class A Common Stock.
• Dmytruk disposed of 49,162 shares of Class A Common Stock on July 2, 2024, at a price of $0.326 per share.
• These sales were to cover tax withholding obligations related to the vesting of restricted stock and/or restricted stock units.
• Following the reported transactions, Dmytruk beneficially owns 1,043,626 shares of Class A Common Stock and 623,777 shares of Class B Common Stock.
• He also holds derivative securities including 516,088, 580,000 and 1,008,334 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company insider; it doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
• The sale of shares to cover tax obligations is a common practice and generally doesn't significantly affect the company's operations.

Key Dates